2017 Q4 Form 10-K Financial Statement
#000156459018004917 Filed on March 08, 2018
Income Statement
| Concept | 2017 Q4 | 2017 Q3 | 2017 Q2 |
|---|---|---|---|
| Revenue | $21.00K | $53.00K | $105.0K |
| YoY Change | -99.71% | -67.28% | -96.03% |
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $8.540M | $5.310M | $4.980M |
| YoY Change | 14.63% | -52.63% | -42.82% |
| % of Gross Profit | |||
| Research & Development | $17.41M | $16.42M | $14.81M |
| YoY Change | -5.59% | -29.32% | -34.9% |
| % of Gross Profit | |||
| Depreciation & Amortization | $1.970M | $790.0K | $880.0K |
| YoY Change | 185.51% | 27.42% | 60.0% |
| % of Gross Profit | |||
| Operating Expenses | $27.15M | $22.44M | $19.80M |
| YoY Change | 4.87% | -35.87% | -12.97% |
| Operating Profit | -$22.39M | ||
| YoY Change | -35.73% | ||
| Interest Expense | $530.0K | $430.0K | $240.0K |
| YoY Change | 278.57% | 152.94% | 9.09% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$110.0K | -$170.0K | -$230.0K |
| YoY Change | -95.7% | 466.67% | -560.0% |
| Pretax Income | -$27.42M | -$22.13M | -$20.32M |
| YoY Change | 26.13% | -36.21% | -29.91% |
| Income Tax | $0.00 | ||
| % Of Pretax Income | |||
| Net Earnings | -$27.42M | -$22.13M | -$20.32M |
| YoY Change | 26.13% | -36.22% | -29.9% |
| Net Earnings / Revenue | -130576.19% | -41750.94% | -19350.48% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$448.8K | -$383.9K | -$408.9K |
| COMMON SHARES | |||
| Basic Shares Outstanding | |||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2017 Q4 | 2017 Q3 | 2017 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $191.9M | $191.7M | $127.0M |
| YoY Change | 135.69% | 74.91% | -8.63% |
| Cash & Equivalents | $26.58M | $20.72M | $37.68M |
| Short-Term Investments | $165.3M | $171.6M | $89.30M |
| Other Short-Term Assets | $5.000M | $4.600M | $4.400M |
| YoY Change | -26.47% | -19.3% | -30.16% |
| Inventory | $312.0K | ||
| Prepaid Expenses | |||
| Receivables | $900.0K | $800.0K | $800.0K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $198.0M | $197.1M | $132.2M |
| YoY Change | 121.01% | 67.74% | -10.13% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $16.62M | $16.60M | $16.80M |
| YoY Change | -3.23% | -11.23% | -3.45% |
| Goodwill | $2.244M | ||
| YoY Change | 13.85% | ||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $1.270M | $1.900M | $900.0K |
| YoY Change | 280.24% | 111.11% | -10.0% |
| Total Long-Term Assets | $20.76M | $20.70M | $19.80M |
| YoY Change | 3.39% | -5.05% | -3.41% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $198.0M | $197.1M | $132.2M |
| Total Long-Term Assets | $20.76M | $20.70M | $19.80M |
| Total Assets | $218.8M | $217.8M | $152.0M |
| YoY Change | 99.48% | 56.35% | -9.31% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $4.539M | $2.200M | $700.0K |
| YoY Change | 19.57% | -42.11% | -84.44% |
| Accrued Expenses | $9.695M | $10.60M | $10.40M |
| YoY Change | -13.38% | -60.3% | -56.12% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $18.59M | $12.90M | $11.10M |
| YoY Change | -7.04% | -57.7% | -60.64% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $643.0K | $500.0K | $400.0K |
| YoY Change | 45.15% | 0.0% | -33.33% |
| Total Long-Term Liabilities | $643.0K | $500.0K | $400.0K |
| YoY Change | 45.15% | 0.0% | -33.33% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $18.59M | $12.90M | $11.10M |
| Total Long-Term Liabilities | $643.0K | $500.0K | $400.0K |
| Total Liabilities | $19.24M | $13.40M | $11.40M |
| YoY Change | -6.07% | -56.77% | -60.42% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$907.3M | ||
| YoY Change | 11.72% | ||
| Common Stock | $1.108B | ||
| YoY Change | 22.4% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $199.5M | $204.4M | $140.5M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $218.8M | $217.8M | $152.0M |
| YoY Change | 99.48% | 56.35% | -9.31% |
Cashflow Statement
| Concept | 2017 Q4 | 2017 Q3 | 2017 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$27.42M | -$22.13M | -$20.32M |
| YoY Change | 26.13% | -36.22% | -29.9% |
| Depreciation, Depletion And Amortization | $1.970M | $790.0K | $880.0K |
| YoY Change | 185.51% | 27.42% | 60.0% |
| Cash From Operating Activities | -$17.75M | -$17.13M | -$17.39M |
| YoY Change | -32.46% | -39.28% | -31.62% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$300.0K | -$130.0K | -$10.00K |
| YoY Change | -75.81% | -91.88% | -99.57% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $6.360M | -$82.22M | -$25.39M |
| YoY Change | -78.35% | -398.11% | -285.33% |
| Cash From Investing Activities | $6.060M | -$82.35M | -$25.40M |
| YoY Change | -78.45% | -416.97% | -322.81% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 18.08M | 81.71M | 58.66M |
| YoY Change | -8318.18% | 20851.28% | 293200.0% |
| NET CHANGE | |||
| Cash From Operating Activities | -17.75M | -17.13M | -17.39M |
| Cash From Investing Activities | 6.060M | -82.35M | -25.40M |
| Cash From Financing Activities | 18.08M | 81.71M | 58.66M |
| Net Change In Cash | 6.390M | -17.77M | 15.87M |
| YoY Change | 294.44% | 865.76% | -213.28% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$17.75M | -$17.13M | -$17.39M |
| Capital Expenditures | -$300.0K | -$130.0K | -$10.00K |
| Free Cash Flow | -$17.45M | -$17.00M | -$17.38M |
| YoY Change | -30.31% | -36.11% | -24.83% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
854000 | |
| CY2017Q4 | us-gaap |
Inventory Net
InventoryNet
|
312000 | |
| CY2017Q4 | us-gaap |
Intangible Assets Current
IntangibleAssetsCurrent
|
1306000 | |
| CY2016Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
6842000 | |
| CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
89599000 | |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
17174000 | |
| CY2016Q4 | us-gaap |
Assets
Assets
|
109680000 | |
| CY2016Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3796000 | |
| CY2016Q4 | us-gaap |
Goodwill
Goodwill
|
1971000 | |
| CY2016Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
602000 | |
| CY2016Q4 | dvax |
Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
|
5048000 | |
| CY2016Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
11192000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
81415000 | |
| CY2015 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
22180000 | |
| CY2017 | us-gaap |
Operating Expenses
OperatingExpenses
|
96332000 | |
| CY2016 | us-gaap |
Operating Expenses
OperatingExpenses
|
121750000 | |
| CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-96005000 | |
| CY2015 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
291000 | |
| CY2016 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
37257000 | |
| CY2015 | us-gaap |
Operating Expenses
OperatingExpenses
|
109123000 | |
| CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
64988000 | |
| CY2017 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-83000 | |
| CY2016 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-694000 | |
| CY2015 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-1261000 | |
| CY2017 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
2826000 | |
| CY2016 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-686000 | |
| CY2017 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-486000 | |
| CY2016 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-2.92 | |
| CY2015 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-1272000 | |
| CY2017 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.81 | |
| CY2016 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
755000 | |
| CY2016 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38506000 | |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-95154000 | |
| CY2015 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-3.25 | |
| CY2017 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
52613000 | |
| CY2015 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
32881000 | |
| CY2015 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
11000 | |
| CY2017 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1337000 | |
| CY2016 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-2492000 | |
| CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-112444000 | |
| CY2017 | dvax |
Reversal Of Deferred Rent Upon Lease Amendment
ReversalOfDeferredRentUponLeaseAmendment
|
209000 | |
| CY2016Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
334000 | |
| CY2017 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1194000 | |
| CY2017 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
27367000 | |
| CY2017 | us-gaap |
Restructuring Charges
RestructuringCharges
|
2783000 | |
| CY2015 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-1671000 | |
| CY2017 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
2743000 | |
| CY2017 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-92411000 | |
| CY2015 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-108055000 | |
| CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
100482000 | |
| CY2015 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
2000 | |
| CY2015 | dvax |
Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
|
531000 | |
| CY2015 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
291000 | |
| CY2015 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
183897000 | |
| CY2015 | dvax |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
228000 | |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
187079000 | |
| CY2016 | dvax |
Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
|
-83000 | |
| CY2016 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
615000 | |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
14728000 | |
| CY2017 | dvax |
Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
|
1613000 | |
| CY2017 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
293000 | |
| CY2017 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
185936000 | |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
14917000 | |
| CY2017 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
3244000 | |
| CY2016 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2257000 | |
| CY2015 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1365000 | |
| CY2016 | dvax |
Write Off Of Assets In Progress
WriteOffOfAssetsInProgress
|
862000 | |
| CY2017 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
10000 | |
| CY2016 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-91000 | |
| CY2015 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-46000 | |
| CY2017 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
193000 | |
| CY2016 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-178000 | |
| CY2015 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-660000 | |
| CY2015 | dvax |
Accretion Of Debt Discounts Related To Debt Financing
AccretionOfDebtDiscountsRelatedToDebtFinancing
|
-115000 | |
| CY2016 | dvax |
Cash Settled Portion Of Stock Based Compensation Expense
CashSettledPortionOfStockBasedCompensationExpense
|
602000 | |
| CY2015 | dvax |
Cash Settled Portion Of Stock Based Compensation Expense
CashSettledPortionOfStockBasedCompensationExpense
|
387000 | |
| CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
14917000 | |
| CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
14126000 | |
| CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
9316000 | |
| CY2017 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-488000 | |
| CY2016 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-52000 | |
| CY2017 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
312000 | |
| CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1830000 | |
| CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-560000 | |
| CY2015 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1631000 | |
| CY2017 | dvax |
Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
|
936000 | |
| CY2017 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1915000 | |
| CY2017 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
3198000 | |
| CY2016 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-2654000 | |
| CY2015 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
205000 | |
| CY2017 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
295000 | |
| CY2015 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
317000 | |
| CY2017 | us-gaap |
Revenues
Revenues
|
327000 | |
| CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-110707000 | |
| CY2016 | us-gaap |
License And Services Revenue
LicenseAndServicesRevenue
|
884000 | |
| CY2017 | us-gaap |
License And Services Revenue
LicenseAndServicesRevenue
|
32000 | |
| CY2017 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
191900000 | |
| CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-106794000 | |
| CY2016 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-8000 | |
| CY2016 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-113138000 | |
| CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-105073000 | |
| CY2015 | us-gaap |
Interest Expense
InterestExpense
|
572000 | |
| CY2015 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
667000 | |
| CY2016 | dvax |
Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
|
103000 | |
| CY2015 | dvax |
Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
|
211000 | |
| CY2016 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1181000 | |
| CY2015 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1246000 | |
| CY2016 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-11759000 | |
| CY2015 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
9017000 | |
| CY2015 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-10111000 | |
| CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-92559000 | |
| CY2015 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
208936000 | |
| CY2015 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
130110000 | |
| CY2015 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
6970000 | |
| CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-85796000 | |
| CY2016 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
615000 | |
| CY2017 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.86%;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Management’s estimates are based on historical information available as of the date of the consolidated financial statements and various other assumptions we believe are reasonable under the circumstances. Actual results could differ materially from these estimates.</p></div> | |
| CY2017 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.86%;">We determine our segments based on the way we organize our business by making operating decisions and assessing performance. In fiscal years 2017, 2016 and 2015, 90%, 92% and 85% of our revenues were earned in the United States, respectively, and the remaining revenues were earned in Germany. As of December 31, 2017 and 2016, 15% and 17%, respectively, of our long-lived assets were located in the United States and the remaining long-lived assets were located in Germany.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.86%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that are subject to concentration of credit risk consist primarily of cash equivalents, marketable securities and accounts receivable. Our policy is to invest cash in institutional money market funds and marketable securities of the U.S. government and corporate issuers with high credit quality to limit the amount of credit exposure. We currently maintain a portfolio of cash equivalents and marketable securities in a variety of securities, including short-term money market funds, U.S. Treasuries, U.S. government agency securities and corporate debt securities. We have not experienced any losses on our cash equivalents and marketable securities. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.86%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our product candidates will require approval from the FDA and foreign regulatory agencies before commercial sales can commence. There can be no assurance that our products will receive any of these required approvals. The denial or delay of such approvals may have a material adverse impact on our business and may impact our business in the future. In addition, after the approval of HEPLISAV-B by the FDA, there is still an ongoing risk of adverse events that did not appear during the drug approval process.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.86%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of product candidates, product liability, the volatility of our stock price and the need to obtain additional financing.</p></div> | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-77518000 | |
| CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-107051000 | |
| CY2017 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
227672000 | |
| CY2016 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
126754000 | |
| CY2017 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
119638000 | |
| CY2016 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
220760000 | |
| CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
669000 | |
| CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
7757000 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-108703000 | |
| CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
86249000 | |
| CY2017 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
185936000 | |
| CY2015 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
183897000 | |
| CY2015 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
10988000 | |
| CY2017 | dvax |
Proceeds Withholdings From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsWithholdingsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
|
1613000 | |
| CY2016 | dvax |
Proceeds Withholdings From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsWithholdingsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
|
-84000 | |
| CY2015 | dvax |
Proceeds Withholdings From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsWithholdingsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
|
531000 | |
| CY2017 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
293000 | |
| CY2015 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
228000 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
187842000 | |
| CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
531000 | |
| CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
173959000 | |
| CY2017 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
674000 | |
| CY2016 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-252000 | |
| CY2015 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-303000 | |
| CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2295000 | |
| CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-20523000 | |
| CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-4699000 | |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
44812000 | |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
49511000 | |
| CY2015 | us-gaap |
Interest Paid
InterestPaid
|
720000 | |
| CY2016 | dvax |
Accrual For Litigation Settlement And Insurance Recovery
AccrualForLitigationSettlementAndInsuranceRecovery
|
4975000 | |
| CY2017 | dvax |
Release Of Accrual For Litigation Settlement And Insurance Recovery
ReleaseOfAccrualForLitigationSettlementAndInsuranceRecovery
|
4975000 | |
| CY2017 | dvax |
Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
|
86000 | |
| CY2016 | dvax |
Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
|
2354000 | |
| CY2015 | dvax |
Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
|
1436000 | |
| CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5981000 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3975000 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
535000 | |
| CY2017 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
144000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3555000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
3533000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2294000 | |
| CY2016Q4 | dvax |
Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
|
21.38 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
12.23 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
14.28 | |
| CY2017Q4 | dvax |
Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
|
19.56 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
19.56 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
21.35 | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y14D | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P6Y14D | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y9M7D | |
| CY2016 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
200000 | |
| CY2017 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
0 | |
| CY2017 | us-gaap |
Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
|
0 | |
| CY2016 | us-gaap |
Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
|
0 | |
| CY2015 | us-gaap |
Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
|
0 | |
| CY2017 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
| CY2016 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
| CY2015 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
| CY2017Q4 | us-gaap |
Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
|
0 | |
| CY2016Q4 | us-gaap |
Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
|
0 | |
| CY2017Q4 | us-gaap |
Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
|
0 | |
| CY2016Q4 | us-gaap |
Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
|
0 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
191934000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
81411000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
8000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
80000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
4000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
191854000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
165350000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
0 | |
| CY2017Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
165350000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
165270000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
0 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
|
165270000 | |
| CY2017 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
0 | |
| CY2016 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
0 | |
| CY2015 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
0 | |
| CY2017Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
300000 | |
| CY2017 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | |
| CY2017Q4 | dvax |
Finite Lived Intangible Assets Current Gross
FiniteLivedIntangibleAssetsCurrentGross
|
2500000 | |
| CY2017Q4 | dvax |
Finite Lived Intangible Assets Current Accumulated Amortization
FiniteLivedIntangibleAssetsCurrentAccumulatedAmortization
|
1194000 | |
| CY2017Q4 | dvax |
Finite Lived Intangible Assets Current Net
FiniteLivedIntangibleAssetsCurrentNet
|
1306000 | |
| CY2017 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P2M | |
| CY2017 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | |
| CY2017Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
12104000 | |
| CY2016Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
10086000 | |
| CY2017Q4 | dvax |
Laboratory Equipment Gross
LaboratoryEquipmentGross
|
6686000 | |
| CY2016Q4 | dvax |
Laboratory Equipment Gross
LaboratoryEquipmentGross
|
6280000 | |
| CY2017Q4 | dvax |
Computer Equipment Gross
ComputerEquipmentGross
|
4760000 | |
| CY2016Q4 | dvax |
Computer Equipment Gross
ComputerEquipmentGross
|
4010000 | |
| CY2017Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
1629000 | |
| CY2016Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
1566000 | |
| CY2017Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
10873000 | |
| CY2016Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
8942000 | |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
|
1176000 | |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
|
2298000 | |
| CY2017 | dvax |
Share Based Compensation Arrangement By Share Based Payment Award Options And Rsu Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber
|
60000 | |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
37228000 | |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
33182000 | |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
20609000 | |
| CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
16008000 | |
| CY2017Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
6180000 | |
| CY2016Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
3753000 | |
| CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
346000 | |
| CY2016Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
275000 | |
| CY2016Q4 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
4975000 | |
| CY2017Q4 | dvax |
Accrued Third Party Research Expenses Current
AccruedThirdPartyResearchExpensesCurrent
|
3567000 | |
| CY2016Q4 | dvax |
Accrued Third Party Research Expenses Current
AccruedThirdPartyResearchExpensesCurrent
|
2784000 | |
| CY2017Q4 | dvax |
Accrued Third Party Development Expenses Current
AccruedThirdPartyDevelopmentExpensesCurrent
|
522000 | |
| CY2016Q4 | dvax |
Accrued Third Party Development Expenses Current
AccruedThirdPartyDevelopmentExpensesCurrent
|
2002000 | |
| CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
3439000 | |
| CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2451000 | |
| CY2017Q4 | dvax |
Accrued Research And Development Expenses And Accrued Liabilities Current
AccruedResearchAndDevelopmentExpensesAndAccruedLiabilitiesCurrent
|
14054000 | |
| CY2016Q4 | dvax |
Accrued Research And Development Expenses And Accrued Liabilities Current
AccruedResearchAndDevelopmentExpensesAndAccruedLiabilitiesCurrent
|
16240000 | |
| CY2017 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
2400000 | |
| CY2016 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
2200000 | |
| CY2015 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
2000000 | |
| CY2017Q4 | us-gaap |
Deferred Rent Credit
DeferredRentCredit
|
600000 | |
| CY2016Q4 | us-gaap |
Deferred Rent Credit
DeferredRentCredit
|
300000 | |
| CY2016 | us-gaap |
Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
|
-300000 | |
| CY2017Q4 | dvax |
Operating Leases And Purchase Commitments Future Minimum Payments Due Current
OperatingLeasesAndPurchaseCommitmentsFutureMinimumPaymentsDueCurrent
|
7743000 | |
| CY2017Q4 | dvax |
Operating Leases And Purchase Commitments Future Minimum Payments Due In Two Years
OperatingLeasesAndPurchaseCommitmentsFutureMinimumPaymentsDueInTwoYears
|
2559000 | |
| CY2017Q4 | dvax |
Operating Leases And Purchase Commitments Future Minimum Payments Due In Three Years
OperatingLeasesAndPurchaseCommitmentsFutureMinimumPaymentsDueInThreeYears
|
2621000 | |
| CY2017Q4 | dvax |
Operating Leases And Purchase Commitments Future Minimum Payments Due In Four Years
OperatingLeasesAndPurchaseCommitmentsFutureMinimumPaymentsDueInFourYears
|
2549000 | |
| CY2017Q4 | dvax |
Operating Leases And Purchase Commitments Future Minimum Payments Due In Five Years
OperatingLeasesAndPurchaseCommitmentsFutureMinimumPaymentsDueInFiveYears
|
2543000 | |
| CY2017Q4 | dvax |
Operating Leases And Purchase Commitments Future Minimum Payments Due Thereafter
OperatingLeasesAndPurchaseCommitmentsFutureMinimumPaymentsDueThereafter
|
6595000 | |
| CY2017Q4 | dvax |
Operating Leases And Purchase Commitments Future Minimum Payments Due
OperatingLeasesAndPurchaseCommitmentsFutureMinimumPaymentsDue
|
24610000 | |
| CY2017 | us-gaap |
Loss Contingency Settlement Agreement Date
LossContingencySettlementAgreementDate
|
September 7, 2016 | |
| CY2017Q4 | us-gaap |
Loss Contingency Accrual Payments
LossContingencyAccrualPayments
|
900000 | |
| CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4673000 | |
| CY2015 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3086000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
7477000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
7468000 | |
| CY2017Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
2702000 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
900000 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
200000 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
400000 | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
13000000 | |
| CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
12100000 | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
6900000 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
| CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
14917000 | |
| CY2016 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
14126000 | |
| CY2015 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
9316000 | |
| CY2017 | dvax |
Cash Settled Portion Of Stock Based Compensation Expense
CashSettledPortionOfStockBasedCompensationExpense
|
0 | |
| CY2017 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
200000 | |
| CY2015 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
200000 | |
| CY2017Q1 | us-gaap |
Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
|
0.40 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-95898000 | |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-114484000 | |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-107450000 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
744000 | |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
2040000 | |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
656000 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-95154000 | |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-112444000 | |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-106794000 | |
| CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
| CY2015 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
| CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
| CY2017 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-32352000 | |
| CY2016 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-38183000 | |
| CY2015 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-36301000 | |
| CY2017 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-4482000 | |
| CY2016 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-334000 | |
| CY2015 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-394000 | |
| CY2017 | us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
1960000 | |
| CY2016 | us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
1950000 | |
| CY2015 | us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
2622000 | |
| CY2017 | dvax |
Income Tax Reconciliation Deferred Compensation Charges
IncomeTaxReconciliationDeferredCompensationCharges
|
3823000 | |
| CY2016 | dvax |
Income Tax Reconciliation Deferred Compensation Charges
IncomeTaxReconciliationDeferredCompensationCharges
|
3016000 | |
| CY2015 | dvax |
Income Tax Reconciliation Deferred Compensation Charges
IncomeTaxReconciliationDeferredCompensationCharges
|
1481000 | |
| CY2017 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-109165000 | |
| CY2016 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
36751000 | |
| CY2015 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
36766000 | |
| CY2017 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
86943000 | |
| CY2017 | dvax |
Income Tax Reconciliation Net Operating Loss And Tax Credit Limitation
IncomeTaxReconciliationNetOperatingLossAndTaxCreditLimitation
|
56962000 | |
| CY2017 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
231000 | |
| CY2016 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
700000 | |
| CY2015 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
1070000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
146300000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
249510000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
29658000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
29463000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
6551000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
8684000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1422000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
4457000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
731000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1303000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
184662000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
293417000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
184388000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
293145000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
274000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
272000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
274000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
272000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
274000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
272000 | |
| CY2017 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-108800000 | |
| CY2016 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
36400000 | |
| CY2015 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
36200000 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
| CY2017Q4 | dvax |
Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Assets Net
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetsNet
|
87000000 | |
| CY2017Q4 | dvax |
Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Assets Valuation Allowance
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetsValuationAllowance
|
87000000 | |
| CY2017Q4 | dvax |
Tax Cuts And Jobs Act Of2017 Change In Tax Rate Undistributed Accumulated Earnings Of Foreign Subsidiary
TaxCutsAndJobsActOf2017ChangeInTaxRateUndistributedAccumulatedEarningsOfForeignSubsidiary
|
700000 | |
| CY2017Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1229000 | |
| CY2016Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
2426000 | |
| CY2017Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
0 | |
| CY2017 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
1197000 | |
| CY2017 | us-gaap |
Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
|
0 | |
| CY2017 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
|
0 | |
| CY2017Q1 | us-gaap |
Revenues
Revenues
|
148000 | |
| CY2017Q2 | us-gaap |
Revenues
Revenues
|
105000 | |
| CY2017Q3 | us-gaap |
Revenues
Revenues
|
53000 | |
| CY2017Q4 | us-gaap |
Revenues
Revenues
|
21000 | |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-25287000 | |
| CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20318000 | |
| CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-22128000 | |
| CY2017Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27421000 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.60 | |
| CY2017Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.41 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.38 | |
| CY2017Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.45 | |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
41830000 | |
| CY2017Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
49700000 | |
| CY2017Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
57650000 | |
| CY2017Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
61007000 | |
| CY2016Q1 | us-gaap |
Revenues
Revenues
|
942000 | |
| CY2016Q2 | us-gaap |
Revenues
Revenues
|
2647000 | |
| CY2016Q3 | us-gaap |
Revenues
Revenues
|
162000 | |
| CY2016Q4 | us-gaap |
Revenues
Revenues
|
7292000 | |
| CY2016Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27023000 | |
| CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-28986000 | |
| CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-34694000 | |
| CY2016Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-21741000 | |
| CY2016Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.70 | |
| CY2016Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.75 | |
| CY2016Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.90 | |
| CY2016Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.56 | |
| CY2016Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38472000 | |
| CY2016Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38496000 | |
| CY2016Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38512000 | |
| CY2016Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38544000 |
